샘플 요청 목록

 카트 문의
시장보고서
상품코드
1595003

지혈 제품 시장

Hemostasis Products
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 196 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 지혈 제품 시장은 2030년까지 179억 달러에 달할 전망

2023년에 138억 달러로 추정되는 세계의 지혈 제품 시장은 2023-2030년 CAGR 3.8%로 성장하며, 2030년에는 179억 달러에 달할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 수액 지혈 제품은 CAGR 3.4%를 기록하며, 분석 기간 종료시에는 86억 달러에 달할 것으로 예측됩니다. 국소 지혈 제품 분야의 성장률은 분석 기간 중 CAGR 3.9%로 추정됩니다.

미국 시장은 37억 달러로 추정, 중국은 CAGR 6.2%로 성장 예측

미국의 지혈 제품 시장은 2023년에 37억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2023-2030년의 CAGR 6.2%를 견인하는 형태로, 2030년까지 예측 시장 규모 36억 달러에 달할 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.0%와 3.1%로 예측됩니다. 유럽에서는 독일이 CAGR 2.5%로 성장할 것으로 예측됩니다.

세계의 지혈 제품 시장 - 주요 동향과 촉진요인 정리

지혈 제품은 외과수술 및 외상 치료에 어떻게 필수적인가?

지혈 제품은 수술 및 외상시 출혈을 조절하여 환자의 안전을 보장하고 합병증을 최소화하는 데 필수적입니다. 외용제, 실란트, 지혈 드레싱 등 지혈 제품들은 즉각적으로 출혈을 조절하여 외과 의사가 보다 안전하게 수술할 수 있도록 돕습니다. 응급 외상 치료에서 지혈 제품은 과도한 출혈을 방지하고 중증 환자의 생존율을 향상시키는 데 필수적입니다. 전 세계에서 수술 및 외상 사례가 증가함에 따라 신뢰할 수 있고 효과적인 지혈 솔루션에 대한 수요가 증가하고 있습니다.

고급 지혈 솔루션에 대한 수요가 증가하는 이유는 무엇인가?

의료 서비스 프로바이더들이 보다 빠르고 효과적인 출혈 제어를 제공하는 제품을 찾고 있으므로 첨단 지혈 솔루션에 대한 수요가 증가하고 있습니다. 피브린 실란트, 콜라겐 기반 드레싱 재료, 유전자 재조합 트롬빈과 같은 기술 혁신은 응고 능력을 향상시키고 수술 시간을 단축하며 환자 결과를 개선할 수 있습니다. 또한 최소침습 수술은 정확한 지혈 제품을 필요로 하며, 이는 첨단 솔루션에 대한 수요를 견인하고 있습니다. 의료 시스템이 효율성과 환자 안전을 우선시함에 따라 첨단 지혈 제품은 최신 수술 의료에 필수적인 요소로 자리 잡고 있습니다.

헤모스타시스 제품 채택에 있으며, 규제 승인의 역할은 무엇인가?

지혈 제품 시장에서는 중요한 출혈 조절에 사용되는 제품의 안전성과 유효성이 가장 중요하므로 FDA 및 EMA와 같은 규제기관은 지혈 제품이 엄격한 임상시험이 필요한 엄격한 품질 기준을 충족하도록 보장합니다. 승인된 제품은 신뢰도가 높고 의료 현장에서 더 널리 채택되므로 규제 준수는 시장 성공의 중요한 요소로 작용하고 있습니다. 안전하고 효과적인 제품은 의료 시설에서 우선순위가 높기 때문에 규제 당국의 승인을 받은 지혈 솔루션은 환자 치료의 품질 기준을 유지하는 데 필수적입니다.

지혈 제품 시장의 성장 원동력은 무엇인가?

지혈 제품 시장 성장의 원동력은 외과수술 증가, 고급 지혈 솔루션에 대한 수요, 엄격한 규제 기준입니다. 수술 건수 증가와 외상 사례 증가는 의료 현장에서 효과적인 지혈 제품에 대한 수요를 촉진하고 있습니다. 빠른 효과를 발휘하는 실란트, 강화된 응고제 등 제품 설계의 발전은 환자의 예후를 개선하고 수술실에 없어서는 안 될 필수품이 되었습니다. 또한 제품의 안전성과 유효성에 대한 규제 요건이 시장 성장을 더욱 촉진하고 있으며, 지혈 제품은 중요하고 일상적인 수술 치료에 필수적인 툴이 되고 있습니다.

부문

제품(침윤성 지혈제, 국소 지혈제, 첨단 지혈제), 용도(혈우병, 외상, 외과수술, 심근경색, 뇌졸중, 혈전증)

조사 대상 기업의 예(총 46건)

  • Abbott Laboratories, Inc.
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • CSL Behring
  • Grifols SA
  • Integra Life Sciences Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Pfizer, Inc.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 24.11.26

Global Hemostasis Products Market to Reach US$17.9 Billion by 2030

The global market for Hemostasis Products estimated at US$13.8 Billion in the year 2023, is expected to reach US$17.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Infusible Hemostasis Products, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Topical Hemostasis Products segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 6.2% CAGR

The Hemostasis Products market in the U.S. is estimated at US$3.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 6.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Hemostasis Products Market - Key Trends & Drivers Summarized

How Are Hemostasis Products Essential in Surgical and Trauma Care?

Hemostasis products are vital in controlling bleeding during surgeries and trauma situations, ensuring patient safety and minimizing complications. These products, which include topical agents, sealants, and hemostatic dressings, provide immediate bleeding control, allowing surgeons to perform procedures more safely. In emergency trauma care, hemostasis products are essential for preventing excessive blood loss, improving survival rates in critical cases. As surgical procedures and trauma cases increase worldwide, demand for reliable and effective hemostasis solutions is growing.

Why Is Demand for Advanced Hemostasis Solutions Increasing?

Demand for advanced hemostasis solutions is on the rise, as healthcare providers seek products that offer faster and more effective bleeding control. Innovations such as fibrin sealants, collagen-based dressings, and recombinant thrombin provide enhanced clotting capabilities, reducing surgical time and improving patient outcomes. Minimally invasive surgeries also require hemostasis products with precise application, driving demand for advanced solutions. As healthcare systems prioritize efficiency and patient safety, advanced hemostasis products are becoming essential in modern surgical care.

What Role Does Regulatory Approval Play in Hemostasis Product Adoption?

Regulatory approval is crucial in the hemostasis products market, as safety and efficacy are paramount for products used in critical bleeding control. Regulatory agencies such as the FDA and EMA ensure that hemostasis products meet stringent quality standards, requiring rigorous clinical testing. Approved products gain greater trust and are more widely adopted in healthcare settings, making regulatory compliance a key factor in market success. With healthcare facilities prioritizing safe and effective products, regulatory-approved hemostasis solutions are essential for maintaining quality standards in patient care.

What Drives the Growth of the Hemostasis Products Market?

The growth in the hemostasis products market is driven by increasing surgical procedures, demand for advanced bleeding control solutions, and strict regulatory standards. Rising surgical volumes and trauma cases are fueling demand for effective hemostasis products in healthcare settings. Advances in product design, such as fast-acting sealants and enhanced clotting agents, support better patient outcomes, making them indispensable in operating rooms. Additionally, regulatory requirements for product safety and efficacy further support market growth, positioning hemostasis products as essential tools in critical and routine surgical care.

SCOPE OF STUDY:

The report analyzes the Hemostasis Products market in terms of US$ Million by the following Application; Product, and Geographic Regions/Countries:

Segments:

Product (Infusible Hemostasis, Topical Hemostasis, Advanced Hemostasis); Application (Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke, Thrombosis)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories, Inc.
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • CSL Behring
  • Grifols SA
  • Integra Life Sciences Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Pfizer, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Hemostasis Products - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Effective Bleeding Control Solutions in Trauma Care
    • Growth in Hemostatic Agents and Dressings for Surgical Use
    • Increasing Adoption of Topical Hemostats in Outpatient Settings
    • Expansion of Hemostasis Products in Dental and Orthopedic Procedures
    • Higher Demand for Advanced Wound Care Products in Hemostasis
    • Development of Biocompatible and Fast-Acting Hemostatic Products
    • Increased Use of Hemostatic Dressings in Military and Emergency Care
    • Growth in Demand for Hemostasis Products in Oncology and Critical Care
    • Expansion of Hemostatic Agents in Minimally Invasive Surgeries
    • Growth of E-commerce Platforms Offering Hemostatic Products
    • Rising Adoption of Hemostasis Products in Sports Medicine
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hemostasis Products Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hemostasis Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hemostasis Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Hemostasis Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Infusible Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Infusible Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Infusible Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Topical Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Topical Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Topical Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Advanced Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Advanced Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Advanced Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hemophilia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hemophilia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hemophilia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Trauma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Myocardial Infarction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Myocardial Infarction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Myocardial Infarction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Stroke by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Thrombosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • JAPAN
    • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • CHINA
    • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • EUROPE
    • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hemostasis Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hemostasis Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Hemostasis Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • FRANCE
    • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • GERMANY
    • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hemostasis Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hemostasis Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Hemostasis Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • INDIA
    • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hemostasis Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hemostasis Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Hemostasis Products by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hemostasis Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hemostasis Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Hemostasis Products by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
  • AFRICA
    • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제